Genotype | OBI group (AA-GF%) | Control group (AA-GF%) | Disease association indices | |||
---|---|---|---|---|---|---|
(2n = 214) | (2n = 560) | P value | OR | 95% CI | ||
Gln4β/Gln4β | 10 (9.35) | 13 (4.64) | 0.080 | 2.117 | 0.899–4.986 | |
Gln4β/Arg4β | 56 (52.34) | 105 (37.50) | 0.008 | 1.830 | 1.167–2.870 | |
Arg4β/Arg4β | 41 (38.32) | 162 (57.86) | 0.001 | 0.452 | 0.287–0.714 | |
P9 | Ala57β/Asp57β | 2 (1.87) | 9 (3.21) | 0.734 | 0.574 | 0.122–2.699 |
Ala57β/Ser57β | 0 (0.00) | 5 (1.79) | 0.328 | 1.018 | 1.002–1.034 | |
Ala57β/Val57β | 1 (0.93) | 7 (2.50) | 0.453 | 0.368 | 0.045–3.026 | |
Asp57β/Asp57β | 10 (9.35) | 58 (20.71) | 0.009 | 0.395 | 0.194–0.804 | |
Asp57β/Ser57β | 7 (6.54) | 32 (11.43) | 0.153 | 0.543 | 0.232–1.269 | |
Asp57β/Val57β | 56 (52.34) | 114 (40.71) | 0.039 | 1.599 | 1.021–2.503 | |
Ser57β/Ser57β | 1 (0.93) | 3 (1.07) | 1.000 | 0.871 | 0.090–8.467 | |
Ser57β/Val57β | 6 (5.61) | 20 (7.14) | 0.589 | 0.772 | 0.301–1.979 | |
Val57β/Val57β | 24 (22.43) | 32 (11.43) | 0.006 | 2.241 | 1.249–4.021 | |
P9 | His60β/Ser60β | 1 (0.93) | 7 (2.50) | 0.453 | 0.368 | 0.045–3.026 |
His60β/Tyr60β | 2 (1.87) | 14 (5.00) | 0.253 | 0.362 | 0.081–1.620 | |
Ser60β/Ser60β | 24 (22.43) | 32 (11.43) | 0.006 | 2.241 | 1.249–4.021 | |
Ser60β/Tyr60β | 61 (57.01) | 134 (47.86) | 0.107 | 1.445 | 0.922–2.263 | |
Tyr60β/Tyr60β | 19 (17.76) | 93 (33.21) | 0.003 | 0.434 | 0.249–0.756 | |
P4 | Val78β/Val78β | 10 (9.35) | 13 (4.64) | 0.080 | 2.117 | 0.899–4.986 |
Tyr78β/Tyr78β | 42 (39.25) | 162 (57.86) | 0.001 | 0.471 | 0.299–0.742 | |
Val78β/Tyr78β | 55 (51.40) | 105 (37.50) | 0.013 | 1.763 | 1.124–2.764 |